AMARIN CORP PLC\UK Lessee, Operating Lease, Liability, Undiscounted Excess Amount
AMARIN CORP PLC\UK (AMRN) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.67 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-07-29
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.67M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.88M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.11M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2.37M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $1.67M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $1.88M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $2.11M 10-K · filed 2026-03-02 |
| 2025-09-30 | $2.37M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $2.64M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $2.93M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $3.05M 10-K · filed 2025-03-12 |
| 2024-09-30 | $3.33M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $3.48M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $3.75M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $4.05M 10-K · filed 2024-02-29 |
| 2023-09-30 | $4.32M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $4.65M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $4.95M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $5.23M 10-K · filed 2023-03-01 |
| 2022-09-30 | $5.45M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $5.74M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $6.05M 10-Q · filed 2022-05-04 |
| 2021-09-30 | $6.36M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $6.66M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.96M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $7.26M 10-K · filed 2021-02-25 |
| 2020-09-30 | $7.56M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $7.81M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $8.11M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $8.39M 10-K · filed 2020-02-25 |
| 2019-09-30 | $8.67M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $8.94M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $9.20M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |